Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of antibody production after COVID-19 vaccination in volunteer donors
jRCT1071210129Recruiting
- Sponsor
- Tatsuhiko Kawasaki
- Start
- Jan 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Tatsuhiko Kawasaki. Primary endpoints: Change in antibody titer to COVID-19 and Comparison of Abbott and Roche COVID-19 antibody reagents. Started Jan 2022; status: recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT1071210129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071210129.